20:03 EST Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals (RXRX) today
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Unusually active option classes on open November 20th
- Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
- Recursion, Exscientia officially combine to advance drug discovery
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Recursion, Exscientia shareholders approve proposed combination